Yet another lawsuit has been filed against GlaxoSmithKline (GSK) after their drug, Zofran, caused the son of a New Jersey family to be born with a congenital defect. The birth injury lawsuit, which was originally filed in the U.S. District Court for the District of New Jersey, will be moved to the District of Massachusetts where it will be combined with over 230 other lawsuits related to Zofran into MDL 2657.
How Did Zofran Cause the Birth Defect?
According to the lawsuit, the mother in this case took every precaution to ensure that she would give birth to a healthy baby, including taking prenatal vitamins at least six months prior to becoming pregnant and abstaining from caffeine, alcohol, tobacco and other harmful products during pregnancy.
When she did become pregnant, she was diagnosed with hyperemesis gravidarum, which is a condition common to pregnant mothers that causes extreme nausea. The condition can be harmful for both the mother and her baby. When she was taken to the hospital for treatment, doctors used Zofran. She first received treatment though an IV, and then took the pill form every day for the rest of her pregnancy.
The baby was born with club foot, meaning his ankles were turned around internally. The New Jersey family say that their son, soon to be 5 years old, has suffered immense physical and emotional pain due to multiple operations and treatments.
Other common defects associated with Zofran include cleft lip and palate, perforated lungs and heart, kidney defects and more.
GSK falsely advertised Zofran, which was designed as a treatment for nausea resulting from chemotherapy, as a solution to morning sickness during pregnancy. They did so without testing or FDA approval.
If you or a loved one has been harmed by defective drugs such as Zofran, call or fill out an online form today for a free consultation and find out how a drug defect lawyer with Targan & Pender, P.C. can help you.